Raloxifene News and Research

RSS
Raloxifene is an oral selective estrogen receptor modulator (SERM) that has oestrogenic actions on bone and anti-oestrogenic actions on the uterus and breast. It is used in the prevention of osteoporosis in postmenopausal women.
Current Medical Research & Opinion publishes new data on EVISTA for postmenopausal osteoporosis

Current Medical Research & Opinion publishes new data on EVISTA for postmenopausal osteoporosis

Exemestane reduces risk of breast cancer in high-risk, postmenopausal women

Exemestane reduces risk of breast cancer in high-risk, postmenopausal women

Drugs for prevention of breast cancer

Drugs for prevention of breast cancer

Drugs can prevent risk of breast cancer in women, experts say

Drugs can prevent risk of breast cancer in women, experts say

USPSTF recommends women of ages 65 and above to routinely screen for osteoporosis

USPSTF recommends women of ages 65 and above to routinely screen for osteoporosis

Estrogen receptor beta inactivates critical genes, arrests cancer cell growth

Estrogen receptor beta inactivates critical genes, arrests cancer cell growth

Women and cancer today

Women and cancer today

Medtronic's Xpander II receives FDA clearance for vertebral compression fractures

Medtronic's Xpander II receives FDA clearance for vertebral compression fractures

14 global studies on osteoporosis medications FORTEO and EVISTA to be presented at ASBMR 2010

14 global studies on osteoporosis medications FORTEO and EVISTA to be presented at ASBMR 2010

Ligand launches Viviant in Japan and Spain for postmenopausal osteoporosis

Ligand launches Viviant in Japan and Spain for postmenopausal osteoporosis

Raloxifene drug may be useful in treating kidney disease in women: Study

Raloxifene drug may be useful in treating kidney disease in women: Study

Medtronic launches new KYPHON Express Curette for scraping or scoring bone in the spine

Medtronic launches new KYPHON Express Curette for scraping or scoring bone in the spine

Fred Hutchinson Center offers research-based tip sheets on breast cancer

Fred Hutchinson Center offers research-based tip sheets on breast cancer

Lilly's Evista method patents upheld through March of 2014

Lilly's Evista method patents upheld through March of 2014

Study shows physicians reluctant to use finasteride for prostate cancer

Study shows physicians reluctant to use finasteride for prostate cancer

EVISTA improves bone quality as measured by HRpQCT: IIT

EVISTA improves bone quality as measured by HRpQCT: IIT

Watson Laboratories files raloxifene hydrochloride tablet ANDA

Watson Laboratories files raloxifene hydrochloride tablet ANDA

Researchers: Breast cancer prevention and treatment protocols not always clear

Researchers: Breast cancer prevention and treatment protocols not always clear

Raloxifene, tamoxifen remain effective options in prevention of breast cancer, finds 19,490-patient study

Raloxifene, tamoxifen remain effective options in prevention of breast cancer, finds 19,490-patient study

Over 17,000 scientists convene at AACR 101st Annual Meeting 2010

Over 17,000 scientists convene at AACR 101st Annual Meeting 2010